Clin2
NCT06560242Possibly a fitRecruiting

Tracking early sound perception in Fragile X syndrome

Fragile X Syndrome

Part of Brain & nervous system, Genetic & congenital clinical trials.

This study uses safe brain monitoring (fNIRS and EEG) to see how infants with Fragile X syndrome process sounds compared to other infants. The goal is to find early signs of hearing or perception issues.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
6 months to 2.2 years
Study type
Interventional

Who can take part

  • Has Fragile X syndrome, typical development, or was born premature
  • Can sit up on their own
  • English is spoken at home
  • No seizures in the past 6 months
  • If in the typical development or Fragile X group, was not born before 32 weeks of pregnancy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05957549Recruiting
Tracking early sound perception in young children

This study uses special brain-monitoring tools (fNIRS and EEG) to look at how preschool-aged children process sounds. It may help researchers understand early sound perception differences, especially in children with Fragile X Syndrome.

Cincinnati, Ohio
NCT06088589Recruiting
Speech-in-noise in autism and fragile x

This study measures how well people with autism or fragile X syndrome perceive speech in noisy settings, compared to typically developing individuals. It uses EEG to understand brain activity during listening tasks.

Cincinnati, Ohio
NCT06227780Recruiting
Sound therapy for thinking and sensory issues in kids with developmental disorders

This trial tests whether special sound patterns played through headphones can help improve thinking and reduce sensitivity to noise in children with Fragile X syndrome or autism. The study uses a short daily listening program over several weeks to see if it makes a difference.

Cincinnati, Ohio
NCT06261450Not yet recruiting· Phase 2
CBD and brain function study for fragile X syndrome

This study tests whether a daily dose of CBD (a cannabis compound) can change brain activity in people with Fragile X syndrome. It also includes a healthy control group to compare results.

NCT07209462Recruiting· Phase 2
MRM-3379 for Fragile X Syndrome in males

This trial tests an investigational medicine called MRM-3379 in males with Fragile X syndrome. It looks at how the medicine affects thinking and behavior over time.

Phoenix, Arizona
NCT06261502Recruiting· Phase 2
CBD for Anxiety in Fragile X Syndrome

This trial tests if cannabidiol (CBD) can help with anxiety and improve brain function in people with Fragile X syndrome. Participants will receive CBD or a placebo, and may have brain scans (MRI) or magnetic stimulation (TMS) to see how it works.

Sherbrooke, Quebec

Hear when a new Fragile X Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.